2020
DOI: 10.3892/mmr.2020.11075
|View full text |Cite
|
Sign up to set email alerts
|

Petatewalide B alleviates oxygen‑glucose deprivation/reoxygenation‑induced neuronal injury via activation of the AMPK/Nrf2 signaling pathway

Abstract: neuronal injury is a common, and critical, occurrence in clinical ischemic strokes, and can cause irreversible brain damage. However, the precise pathological mechanisms underlying this condition and effective treatment remain unclear. increasing evidence shows that the nuclear factor erythroid 2-related factor 2 (nrf2)/activated protein kinase (AMPK) signaling pathway serves a significant role in neuronal injury and is involved in neuroprotection. The present study demonstrated that petatewalide B, the active… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 19 publications
0
2
0
Order By: Relevance
“…The active ingredient of Petasites japonicus (also known as butterbur), petatewalide B, upregulates the AMPK/Nrf2 signaling pathway to down‐regulate apoptosis and oxidative stress, thereby protecting human neuroblastoma cells from oxygen‐glucose deprivation/reoxygenation‐induced injury, which indicates that petatewalide B may be a potential protective agent for neuronal damage, with possible therapeutic and medical significance (S. Y. Park et al, 2020).…”
Section: Potential Drugs Targeting Ampk‐regulated Pathway In Irimentioning
confidence: 99%
“…The active ingredient of Petasites japonicus (also known as butterbur), petatewalide B, upregulates the AMPK/Nrf2 signaling pathway to down‐regulate apoptosis and oxidative stress, thereby protecting human neuroblastoma cells from oxygen‐glucose deprivation/reoxygenation‐induced injury, which indicates that petatewalide B may be a potential protective agent for neuronal damage, with possible therapeutic and medical significance (S. Y. Park et al, 2020).…”
Section: Potential Drugs Targeting Ampk‐regulated Pathway In Irimentioning
confidence: 99%
“…More recently, the AMPK/Nrf2 signaling pathway is the focus of research and petatewalide B, i.e., a bakkenolide-type sesquiterpine, alleviates oxygen-glucose deprivation/reoxygenation-induced neuronal injury via activation of the AMPK/Nrf2 signaling pathway in the human-derived neuroblastoma cell line SH-SY5Y ( 52 ).…”
Section: Butterbur's Composition and Therapeutic Benefitsmentioning
confidence: 99%